Blood pressure control in eNOS knock-out mice: comparison with other species under NO blockade.

Changes in arterial blood pressure (ABP) lead to changes in vascular shear stress. This mechanical stimulus increases cytosolic Ca2+ in endothelial cells, which in turn activates the endothelial isoform of the nitric oxide synthase. The subsequently formed NO reaches the adjacent vascular smooth muscle cells, where it reduces vascular resistance in order to maintain ABP at its initial level. Thus, NO may play an important role as a physiological blood pressure buffer. Previous data on the importance of eNOS for blood pressure control are reviewed with special emphasis on the fact that endogenous nitric oxide can buffer blood pressure variability (BPV) in dogs, rats and mice. In previous studies where all isoforms of the nitric oxide synthase were blocked pharmacologically, increases in blood pressure and variability were observed. Thus, we set out to clarify which isoform of the nitric oxide synthase is responsible for this BPV controlling effect. Hence, blood pressure control was studied in knock-out mice lacking specifically the gene for endothelial nitric oxide synthase with their respective wild-type controls. One day after surgery, under resting conditions, blood pressure was increased by 47 mmHg (P < 0.05), heart rate was lower (-77 beats min-1, P < 0.05), and BPV doubled (P < 0.05). Based on these results, we conclude that chronic blood pressure levels are influenced by eNOS and that there is a blood pressure buffering effect of endogenous nitric oxide which is mediated by the endothelial isoform of the nitric oxide synthase.

[1]  P. Persson,et al.  Antihypertensive effect of 0.1-Hz blood pressure oscillations to the kidney. , 2000, Circulation.

[2]  R. Mrowka,et al.  Enhanced blood pressure variability in eNOS knockout mice. , 1999, Hypertension.

[3]  H. Bidmon,et al.  Coronary hemodynamics in endothelial NO synthase knockout mice. , 1998, Circulation research.

[4]  I. R. Hutcheson,et al.  Central role of intracellular calcium stores in acute flow‐ and agonist‐evoked endothelial nitric oxide release , 1997, British journal of pharmacology.

[5]  H. Seller,et al.  Neuronal nitric oxide reduces sympathetic excitability by modulation of central glutamate effects in pigs. , 1997, Circulation research.

[6]  Axel Gödecke,et al.  Endothelial nitric oxide synthase and LTP , 1997, Nature.

[7]  H. S. Kim,et al.  Elevated blood pressures in mice lacking endothelial nitric oxide synthase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Elghozi,et al.  Contribution of the renin‐angiotensin system to short‐term blood pressure variability during blockade of nitric oxide synthesis in the rat , 1996, British journal of pharmacology.

[9]  J. Michel,et al.  Sustained increase in aortic endothelial nitric oxide synthase expression in vivo in a model of chronic high blood flow. , 1996, Circulation research.

[10]  R. D'Agostino,et al.  Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality. The Framingham Heart Study 1950 to 1990. , 1996, Circulation.

[11]  R M Nerem,et al.  Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. , 1995, The American journal of physiology.

[12]  M. Moskowitz,et al.  Hypertension in mice lacking the gene for endothelial nitric oxide synthase , 1995, Nature.

[13]  M. Turiel,et al.  Pure Autonomic Failure: complex abnormalities in the neural mechanisms regulating the cardiovascular system. , 1995, Journal of the autonomic nervous system.

[14]  M. Feria,et al.  Effects of N omega-monomethyl-L-arginine on short-term RR interval and systolic blood pressure oscillations. , 1994, Journal of cardiovascular pharmacology.

[15]  M. Kienzle,et al.  Muscle Sympathetic Nerve Activity Is Reduced in IDDM Before Overt Autonomic Neuropathy , 1993, Diabetes.

[16]  D. Levy,et al.  Cardiovascular risks: new insights from Framingham. , 1988, American heart journal.

[17]  P. Persson Modulation of cardiovascular control mechanisms and their interaction. , 1996, Physiological reviews.

[18]  I. Findlay Interactive Regulation of the ATP‐Sensitive Potassium Channel of Cardiac Muscle , 1994, Journal of cardiovascular pharmacology.

[19]  H. Strauss,et al.  Intracellular calcium, currents, and stimulus-response coupling in endothelial cells. , 1993, Hypertension.

[20]  G. Mancia,et al.  Blood Pressure and Organ Damage , 1987, Journal of cardiovascular pharmacology.